Dysport® has proven very successful in treating the appearance of frown lines in the space between the eyebrows. These lines are caused by repeated movement of the facial muscles, and as a result they may appear in people of a variety of ages, often before other wrinkles appear naturally.
What are the benefits of Dysport?
One of the benefits of Dysport treatment is the specificity of the treatment area. By only targeting the area between the eyebrows, the frown lines are relaxed but the rest of the facial muscles are left intact to operate normally. This gives Dysport users a more natural, more relaxed appearance.
What are the steps of the Dysport procedure?
A minimally invasive procedure, Dysport requires no anesthetic. The Dysport is injected through a very thin needle into the necessary facial muscles. Depending on the patient, the number of injections may vary. The treatment often takes less than 15 minutes.
Who is an ideal candidate for Dysport?
Anyone under the age of 65 who is dissatisfied with the frown lines between their eyebrows may be an excellent candidate for Dysport.
Some medical conditions may make patients ill-suited for Dysport, including those with allergies to milk protein, diseases that affect muscles and nerves, breathing problems, swallowing problems and heart problems. Additionally, if candidates have weak facial muscles, facial imbalances, or drooping or sagging eyelids, they may not be ideal candidates for Dysport.
What happens after the procedure?
There is no recovery period following Dysport injection, due to its minimally invasive design. Results should be seen in a few days, with full effect apparent by the end of the week. Usually the benefits of Dysport last for three to four months, and may be repeated as soon as they start to fade.
Are there any side effects?
Possible risk of side effects is minimal, and includes headaches, nose and throat irritation, eyelid swelling or drooping, sinus inflammation, nausea and injection site reaction or pain. Use of any form of botulinum toxin carries the extremely slight risk of the spread of the toxin throughout the body, which may cause spasms and additional symptoms.
Use of human albumin within the Dysport injection gives an extremely low chance of the transmission of Creutzfeldt-Jakob disease, though this has never been recorded.